CS Diagnostics Corp. (CSDX)
0.0105
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CS Diagnostics Shareholders Equity (Quarterly) : 499.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 499.47M |
| September 30, 2025 | 499.43M |
| June 30, 2025 | 499.43M |
| March 31, 2025 | 499.43M |
| December 31, 2024 | 499.40M |
| September 30, 2024 | 499.44M |
| June 30, 2024 | 499.42M |
| March 31, 2024 | 499.42M |
| December 31, 2023 | 499.41M |
| September 30, 2023 | 499.49M |
| June 30, 2023 | 0.0637M |
| March 31, 2023 | 0.0054M |
| December 31, 2022 | -0.0313M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -1.962M |
| June 30, 2015 | -1.957M |
| March 31, 2015 | -1.953M |
| December 31, 2014 | -1.972M |
| September 30, 2014 | -1.963M |
| June 30, 2014 | -1.957M |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aibotics, Inc. | -4.602M |
| GeneDx Holdings Corp. | 244.22M |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 499.49M |
| Total Liabilities (Quarterly) | 0.0153M |
| Current Ratio | 5.595 |